Marvin Kaaka

Mortgage Broker | Owner of Coouge Studios Inc, Twin Mortgages, & Photzo Creative Studios | Software & Web Developer | Real Estate Investor | Trader | Entrepreneur | Content Creator

📍 Canada🔄 Updated September 2026💼 4 investments📅 12 years investing🗓 Last invested Oct 2023
Operator-angel🌍 Canada
4
Total investments
0
Early stage
1
Mid stage
1
Late stage
12y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Oct 2023
Polestar - the guiding star. We are an electric performance brand, determined to improve the society we live in. Our focus is on uncompromised design and technology.  Passion and emotion drive us, electricity and innovation drive our cars. Our products are excellent, efficient and entertaining.  In Polestar’s future, there is no room for shortcuts, excuses or compromises. We are all in, dedicated on our ambition. Guiding our industry forward through pure, progressive, performance. At Polestar, the sky is the limit.
Private Investor
Oct 2017
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
Private Investor
Feb 2014
Vyant Bio (Nasdaq: VYNT) - uniting human biology, engineering, data science, and passion to transform lives
Experience · 6 entries
All (6)
Investments (4)
Founder (2)
2023
Co-Owner
Nov 2023
At Photzo Creative Studio, we specialize in professional editing services tailored to elevate your visual content. Our dedicated team excels in photo editing, video enhancement, and graphic design, offering unparalleled precision and creativity. We cater to diverse needs, from refining images for social media to creating impactful graphics for marketing campaigns. Our commitment is to deliver top-quality editing solutions that breathe life into your visuals, enhancing their appeal and effectiveness. With a keen eye for detail and a passion for creativity, we work closely with our clients to understand their vision and bring it to reality. Our goal is to exceed expectations by providing exceptional editing services that elevate brands and captivate audiences. Experience the difference with Photzo Creative Studio – where your visual content is transformed into compelling, professional-grade assets that leave a lasting impression.
early stageGraphic Design
Private Investor
Oct 2023
Polestar - the guiding star. We are an electric performance brand, determined to improve the society we live in. Our focus is on uncompromised design and technology.  Passion and emotion drive us, electricity and innovation drive our cars. Our products are excellent, efficient and entertaining.  In Polestar’s future, there is no room for shortcuts, excuses or compromises. We are all in, dedicated on our ambition. Guiding our industry forward through pure, progressive, performance. At Polestar, the sky is the limit.
2019
Private Investor
Oct 2019
We’re focused on using our proven vaccine technology to protect health by developing our R&D assets and establishing partnerships. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our mission of ensuring broad access to our vaccines. It’s more than our job. It’s our passion. Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines
2017
Private Investor
Oct 2017
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
2014
Private Investor
Feb 2014
Vyant Bio (Nasdaq: VYNT) - uniting human biology, engineering, data science, and passion to transform lives
Show all 6 entries ↓
Investment activity
2014–2023 · 4 investments
20141201712019120231
Recent (last 2 years)Earlier